Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

Becoming a Doctor – and a Mom

Video of Becoming a Doctor – and a Mom | Ngozi Monu | Weill Cornell Medicine

For Ngozi Monu, the key to success is balance. By the time she entered medical school, she was a two-time Olympian with a doctorate. She then discovered new challenges as she became a mother of two while earning her medical degree. Now Monu is working to balance her home life with her future career as an obstetrician/gynecologist – while striving for excellence in both.

Dr. Matthew Greenblatt Wins Pershing Square Sohn Prize for Young Investigators in Cancer Research

Dr. Matthew Greenblatt, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has been awarded the 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research to support his work studying tumor growth in bone.    

A New Strategy for Protecting the Brain After Strokes

The chemical element selenium, an essential nutrient for humans and other animals, protects the brain after a stroke and may be a basis for future stroke therapies, according to a study from scientists at Burke Neurological Institute and Weill Cornell Medicine.

Tracking the Epigenetic Evolution of a Cancer, Cell by Cell

A powerful new set of scientific tools developed by Weill Cornell Medicine and New York Genome Center (NYGC) researchers enables them to track the molecular evolution of cancers. The tools should enable a better understanding of how cancers arise and spread in the body, and how they respond to different therapies.

Helping Hand

Dr. Omar Vandal, Ph.D. ’07, came to Weill Cornell Graduate School of Medical Sciences determined to make a difference in the world—focusing his studies on tuberculosis, the world’s most deadly infectious disease and one that sickens an estimated half-million people each year in his homeland of Pakistan. He did innovative doctoral research, identifying a key protein that the TB bacterium needs to survive within the host cell—information that may help scientists develop better drugs. But after all those years in the lab, Dr.

Discovery Reveals Potential New Pathway for Treating Obesity and Related Disorders

A molecule that helps prevent fat accumulation in mammals is produced within fat tissues by stem-like cells that may be therapeutic targets for obesity and related disorders, according to a new study from scientists at Weill Cornell Medicine.

Obesity has become a global pandemic in recent decades, and presently affects more than 90 million Americans and hundreds of millions of people worldwide. Obesity can be debilitating on its own, but it also increases the risk of other major diseases including cancers, heart disease, diabetes and immunological disorders.

Astronaut Twins Study Yields New Insights, Algorithms and Portable DNA Sequencing Tools

Long-term spaceflight causes more changes to gene expression than shorter trips, especially to the immune system and DNA repair systems, according to research by Weill Cornell Medicine and NASA investigators as part of NASA’s Twins Study, which followed the only set of identical twin astronauts for more than two years.  

Study Shows How Ketamine Reverses Depression—and How its Benefits Could Be Extended

The powerful but temporary benefits of ketamine against depression might be extended if the new brain-cell connections it promotes could be preserved, according to a new study published April 12 in Science from researchers at Weill Cornell Medicine.

Weill Cornell IMSD Program

Funded by the NIH/NIGMS, the Weill Cornell Initiative for Maximizing Student Development (Weill Cornell IMSD) is a leadership development and community engagement program that aims to train the next generation of scientific leaders in biomedical research who prioritize meaningful community involvement.